2011, Number 5
<< Back Next >>
Med Cutan Iber Lat Am 2011; 39 (5)
Paraneoplastic dermatomyositis
Domínguez Eae, Díaz MM
Language: Spanish
References: 14
Page: 226-229
PDF size: 536.24 Kb.
ABSTRACT
The skin is the target of numerous systemic diseases and its involvement could be the clue to the detection of -not yet manifested- internal disorders. We report a patient with cutaneous lesions that leads to the detection of a metastasic carcinoma.
REFERENCES
Naschitz JE, Rosner I, Rozenbaum M, Zuckerman E, Yeshurun D. Rheumatic syndromes: clues to occult neoplasia. Semin Arthritis Rheum 1999; 29: 43-55.
Buchbinder R, Forbes A, Hall S, Dennett X, Giles G. Incidence of malignant Disease in Biopsy-Proven Inflammatory myopathy. Ann Int Med 2001; 134: 1087-95.
Dabrowska-Zimo A., Brzosko M. A review of paraneoplastic rheumatic síndromes. Ann Acad Med Stetin 2006; 52 (Suppl. 2): 17-22.
Burnouf M, Mahé E, Verpillat P, Deschamps V, Lebrun-Vignes B, Picard-Dahan C et al. Cutaneous necrosis is predictive of cancer in adult dermatomyositis. Ann Dermatol Venereol 2003; 130: 313-6.
Hill C, Zhang Y, Sigurgeirsson B, Pukkala E, Mellemkjaer L, Airio A et al. Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet 2001; 357 (9250): 96-100.
Ashour A, Verschraegen C, Kudelka A, Kavanagh J. Paraneoplastic síndromes of gynecologic neoplasms. J Clin Oncol 1997; 15: 1272-82.
Kurzrock R, Cohen P. Cutaneous paraneoplastic síndromes in solid tumors. Am J Med 1995; 99: 662-71.
Sparsa A, Liozon E, Herrmann F, Ly K, Lebrun V, Soria P et al. Routine vs Extensive Malignacy Search for Adult Dermatomyositis and Polymyostis. Arch Dermatol 2002; 138: 885-90.
Callen JP. When and How Should the Patient With Dermatomyositis or Amyopathic Dermatomyositis Be Assessed for Possible Cancer? Arch Dermatol 2002; 138: 969-71.
Solans R, Párez C, Salud A, Fonollosa P, Rodrigo M, Armadans L, et al. Clinical significance of antinuclear antibodies in malignant diseases: association with rheumatic and connective tissue paraneoplastic síndromes. Lupus 2004; 13: 159-64.
Zahir A, Duhaut P, Huong D, Wechsler B, Costedoat- Chalumeau N, Francès C et al. Tumor Antigen markers for the Detection of Solid Cancers in Inflammatory Myopathies. Cancer Epidemiol Biomarkers Prev 2005; 145: 1279-82.
Crump C, McIntosh W, Urban N, Andreson G, Karlan B. Ovarian Cancer Tumor Marker Behavior in Asymptomatic Healthy Women: Implications for Screening. Cancer Epidemiol Biomarkers Prev 2000; 9: 1107-11.
Kaji K, Fujimoto M, Hasegawa M, kondo M, Saito Y, Komura K et al. Identification of a novel autoantibody reactive with 155 and 140 kDa nuclear proteins in patients with dermatomyositis: an association with malignancy. Rheumatology 2007; 46: 25-8.
Berner U, Menzel C, Rinne D, Kriener S, Hamscho N, Döbert N, et al. Paraneoplastic síndromes: detection of malignant tumors using [(18)F] FDG-PET. Q J Nucl Med 2003; 47: 85-9.
Full text